Home Multimedia Podcasts NOVEL APPROACH TO CANCER DRUG DEVELOPMENT NOVEL APPROACH TO CANCER DRUG DEVELOPMENT May 22, 2008 – Interview with Ronen Marmorstein, Ph.D., Professor, Gene Expression and Regulation Program, Wistar Institute BiomoleculesCancer drug discoveryCancersCellular, Molecular and Developmental BiologyDrug development (Research and development)Drug discoveryDrug research and developmentEnzymesMedicine, Diagnosis, and TherapeuticsMelanomaPharmacologyResearch and developmentSkin cancerSystemic conditions Also of Interest UV-Damaged RNA in Daughter Cells Captured by Stress Granules New DNA Origami Platform, DoriVac, Opens New Path for Designer Cancer Vaccine Development 10x Ships First Single Cell GEM-X Assays to Customers StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies Novel Lensless Light Diffraction Method Detects Viral Infection Related Media Sun, Spatial, and Sequencing: A Video Report from the First Day of AGBT What’s in Store for 2024? Three CEOs Look Ahead and Look Back on “Close to the Edge” Excitement in Oakland: A Report from SynBioBeta BIO CEO Rachel King Outlines Industry's Challenges on "Close to the Edge" Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA Day: An Interview with Eric Green on "The State of Genomics" Related Content UV-Damaged RNA in Daughter Cells Captured by Stress Granules New DNA Origami Platform, DoriVac, Opens New Path for Designer Cancer Vaccine Development 10x Ships First Single Cell GEM-X Assays to Customers StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug